Schedule 13G ownership disclosure
Prime Medicine Inc
Common Stock, par value $0.00001 per share · CUSIP: 74168J101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Newpath Partners, L.P.
Shares: 6,105,679.00 · Class: 4.7%
- Newpath Partners GP, L.P.
Shares: 6,105,679.00 · Class: 4.7%
- Newpath Partners GP, LLC
Shares: 6,105,679.00 · Class: 4.7%
- Thomas Cahill
Shares: 6,105,679.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006876
- Form type
- SCHEDULE 13G/A
- Filer
- Newpath Partners, L.P.
- CIK
- CIK 1755973
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership